First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy

Valicenti Richard K.; Pugh Stephanie L.; Trabulsi Edouard J.; Sartor Oliver; Ko Eric C.; Girvigian Michael R.; Rosenthal Seth A.; Shaves Mark E.; Hoffman-Censits Jeannie H.; Schallenkamp John; Sandler Howard M.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy

【24h】

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy

机译：NRG肿瘤学/放射治疗肿瘤学系列0622的第一个报告：钐-153的第2期试验，然后在自由基前列腺切除术后挽救前列腺髓质癌症的高危临床前列腺癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To investigate the utility of Sm-153 lexidronam (Quadramet) in the setting of men with prostate cancer status post radical prostatectomy who develop biochemical failure with no clinical evidence of osseous metastases.

机译：目的：研究SM-153 lexidronam（四列）在具有前列腺癌现状的男性的效用中的效用，其自由基前列腺切除术后，患有生化失败，没有骨质转移的临床证据。

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2018年第3期|共7页
作者
Valicenti Richard K.; Pugh Stephanie L.; Trabulsi Edouard J.; Sartor Oliver; Ko Eric C.; Girvigian Michael R.; Rosenthal Seth A.; Shaves Mark E.; Hoffman-Censits Jeannie H.; Schallenkamp John; Sandler Howard M.;
展开▼
作者单位

Univ Calif Davis Med Ctr Sacramento CA 95817 USA;

NRG Oncol Stat &

Data Management Ctr Philadelphia PA USA;

Thomas Jefferson Univ Hosp Philadelphia PA 19107 USA;

Tulane Univ New Orleans LA 70118 USA;

Univ Calif Davis Med Ctr Sacramento CA 95817 USA;

Kaiser Permanente Los Angeles Med Ctr Los Angeles CA USA;

Sutter Community Hosp Accruals Radiol Associates Sacramento Sacramento CA USA;

Sentara Norfolk Gen Hosp Norfolk VA USA;

Thomas Jefferson Univ Hosp Philadelphia PA 19107 USA;

Billings Clin Canc Ctr Accruals Montana Canc Consortium CCOP Billings MT USA;

Cedars Sinai Med Ctr Los Angeles CA 90048 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
专利

1. First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy [J] . Valicenti Richard K., Pugh Stephanie L., Trabulsi Edouard J., International Journal of Radiation Oncology, Biology, Physics . 2018,第3期

机译：NRG肿瘤学/放射治疗肿瘤学系列0622的第一个报告：钐-153的第2期试验，然后在自由基前列腺切除术后挽救前列腺髓质癌症的高危临床前列腺癌
2. Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA [J] . Shipley W. U., Seiferheld W., Lukka H., International Journal of Radiation Oncology, Biology, Physics . 2016,第1期

机译：NRG Oncology / RTOG 9601，前列腺癌的三期试验报告：在患有pT2-3pN0疾病的前列腺根治性切除术（RP）和PSA升高的放射治疗（RT）期间和之后，使用比卡鲁胺进行抗雄激素治疗（AAT）
3. Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials [J] . Hallemeier Christopher L., Zhang Peixin, Pisansky Thomas M., International Journal of Radiation Oncology, Biology, Physics . 2019,第5期

机译：前列腺癌前列腺癌前列腺抑制后前列腺癌患者接受短期雄激素抑制和外梁辐射治疗：4个NRG肿瘤治疗肿瘤学系的汇总分析随机临床试验
4. Vascular-Targeted Photodynamic of Prostate Cancer Phase with Tookad for Recurrent Prostate Cancer Following Radiation Therapy: Initial Clinical Studies [C] . Robert A. Weersink, Brian C. Wilson, Arjen Bogaards, Photonic Therapeutics and Diagnostics III; Progress in Biomedical Optics and Imaging; vol.8 no.1; Proceedings of SPIE-The International Society for Optical Engineering; vol.6424 . 2007

机译：Tookad用于前列腺癌放疗后复发性前列腺癌的血管靶向光动力学研究：初步临床研究
5. Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy [D] . KASHIHARA, Tairo 2019

机译：前列腺癌根治术后前列腺癌生化复发的挽救性外照射治疗中手术切缘阳性部位的重要性
6. First Report of NRG Oncology RTOG 0622: A Phase II Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Non-Metastatic Prostate Cancer after Radical Prostatectomy [O] . Richard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, -1

机译：NRG肿瘤学RTOG 0622的第一份报告：mar 153的II期临床试验然后在前列腺癌根治性切除术后高风险临床上非转移性前列腺癌中抢救前列腺窝进行放射治疗。
7. First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy [O] . Richard K. Valicenti, Stephanie L. Pugh, Edouard J. Trabulsi, 2018

机译：NRG肿瘤学/放射治疗肿瘤学系列0622的第一个报告：钐-153的第2期试验，然后在自由基前列腺切除术后挽救前列腺髓质癌症

First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy

摘要

著录项

相似文献

相关主题

期刊订阅